drugset / Trial / NCT01844206

Two Dose Epidural Morphine for Post-cesarean Analgesia

NCT01844206 ↗

Phase 4 Terminated 5 enrolled Columbia University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes scheduled Nonsteroidal anti-inflammatory drugs (NSAIDs). The investigators hypothesize that administration of a second dose of epidural morphine 3 mg, 24 hours after an initial intraoperative dose, will provide superior post-cesarean analgesia during the 2nd 24 hours after surgery, compared to a single epidural morphine dose regimen. The primary outcome will be the amount of intravenous morphine patients self-administer during the 2nd 24 hours post-surgery.

Timeline

Start
2013-06
Primary completion
2014-06
Completion
2014-06

Outcome

Outcome not reported

Stopped (Enrollment): “Slow recruitment of subjects”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 3 mg Other

Indications